Please login to the form below

Not currently logged in
Email:
Password:

Pharmalink appoints Dr Heather Cook and Marek Poszepczynski

Strengthens senior management team

Pharmalink Marek PoszepczynskiPharmalink has bolstered its senior management team with the appointment of Dr Heather Cook and Marek Poszepcynski (pictured).

Dr Cook joins the Swedish specialty pharmaceutical company as director of regulatory affairs from Lundbeck, where she headed up its regulatory development projects department.

Prior to her time with Lundbeck, Dr Cook served at AstraZeneca as its global regulatory affairs director for oncology and a number of other senior roles, including scientific director for neuroscience and infection.

Pharmalink's other senior management appointment is Marek Poszepcynski who takes up the role of director of business development.

He arrives at the company from analysts Handelsbanken, where he covered European and Swedish biotechnology stocks, and before that was vice president of business development at Karolinska Development.

Pharmalink's managing director Johan Häggblad said: "These appointments add significant talent and new experience to Pharmalink's management team as the company continues to drive forward its late stage clinical development programs for Nefecon and Busulipo and actively seeks new product opportunities.

“It is a measure of our reputation that such high caliber executives have joined us and I look forward to working with Heather and Marek through what is an exciting stage of development."

Picture credit: Lenita Gahlin

30th October 2012

From: Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics